These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17484718)

  • 21. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

  • 22. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 23. Information on marketed drugs for doctors and patients. Experience in six European countries.
    Brown P; Charlish P; Brazier H; Butterfield M
    Int J Technol Assess Health Care; 1995; 11(3):410-6. PubMed ID: 7591543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [More than 1 out of 100 will have myocardial infarction and stroke because of enalapril--effect of drug package inserts?].
    Sandström H
    Lakartidningen; 2006 Feb 22-28; 103(8):564, 567; discussion 567. PubMed ID: 16570783
    [No Abstract]   [Full Text] [Related]  

  • 25. [Medicines. Russian roulette at bedside].
    Rüeger M; Muff P
    Krankenpfl Soins Infirm; 2004; 97(3):16-9, 48-51. PubMed ID: 15074251
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug counterfeiting burden remains a guess, experts say.
    Traynor K
    Am J Health Syst Pharm; 2009 Jul; 66(14):1246-8. PubMed ID: 19574593
    [No Abstract]   [Full Text] [Related]  

  • 27. Animal, vegetable, mineral: we need to be informed.
    Foss TD
    Br J Nurs; 2005 Oct 13-26; 14(18):951. PubMed ID: 16237346
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulation of pharmacoeconomics and outcomes research.
    Radensky P
    Value Health; 2001; 4(1):12-5. PubMed ID: 11704968
    [No Abstract]   [Full Text] [Related]  

  • 29. Are consumers provided with adequate information on the actions and uses of ipecacuanha syrup?
    Harris LA; Plumley NF; Straton JA; Ilett KF
    Med J Aust; 1985 Jun; 142(13):690-3. PubMed ID: 2861557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New (still proposed) rules for sunscreen. UVA testing and ranking may be the most important change.
    Harv Health Lett; 2010 Jun; 35(8):6. PubMed ID: 20700956
    [No Abstract]   [Full Text] [Related]  

  • 31. Promotional literature: how do we critically appraise?
    Shetty VV; Karve AV
    J Postgrad Med; 2008; 54(3):217-21. PubMed ID: 18626173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDA's Rx for better medication information.
    Farley D
    FDA Consum; 1995 Nov; 29(9):5-10. PubMed ID: 10152787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Communicating with patients about their medications.
    Kessler DA
    N Engl J Med; 1991 Dec; 325(23):1650-2. PubMed ID: 1944456
    [No Abstract]   [Full Text] [Related]  

  • 34. Adverse-drug-event data provided by pharmaceutical companies.
    Cudny ME; Graham AS
    Am J Health Syst Pharm; 2008 Jun; 65(11):1071-5. PubMed ID: 18499882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open letter on line extensions.
    Krogh C
    Dimens Health Serv; 1990 Nov; 67(8):5. PubMed ID: 2276526
    [No Abstract]   [Full Text] [Related]  

  • 36. [Information on the composition of chemical preparations for sale on the Belgian market].
    Arch Belg; 1988; 46(7-8):389-95. PubMed ID: 3269207
    [No Abstract]   [Full Text] [Related]  

  • 37. History in the making: the evolution of consumer product information (CPI).
    Shenfield GM; Tasker JL
    Med J Aust; 1997 Apr; 166(8):425-8. PubMed ID: 9140350
    [No Abstract]   [Full Text] [Related]  

  • 38. MedGuide: at last a long-sought opportunity for patient education about prescription drugs.
    Marwick C
    JAMA; 1997 Mar; 277(12):949-50. PubMed ID: 9091654
    [No Abstract]   [Full Text] [Related]  

  • 39. Contraindication labelling changes in the United States and Germany.
    Garbe E; Andersohn F
    Eur J Clin Pharmacol; 2007 Jan; 63(1):87-93. PubMed ID: 17124576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacists save thousands of lives: big decrease in dose-related adverse effects.
    Powell JR
    Pharmacotherapy; 2004 Mar; 24(3):422-5. PubMed ID: 15040659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.